PD-0764 Quality of life, toxicity, and PSA control after 50 Gy SBRT to the dominant intraprostatic nodule. (August 2021) - Cloitre, M.; Valerio, M.; Roth, B.; Berthold, D.; Tawadros, T.; Meuwly, J.; Heym, L.; Duclos, F.; Viguet-Carrin, S.; Vallet, V.; Bourhis, J.; Herrera, F.